Kestra Medical Technologies
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.1 percentage points.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 106.26% -0.12pp
- Institutions
- 144 +2
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-09
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 8 buys · 42 sells
| Name | Role | Stake |
|---|---|---|
| Bain Capital, LP | -- | 42.26% |
| Brian Webster | Chief Executive Officer | 0.52% |
| Traci Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | 0.25% |
| Alfred Ford | Chief Commercial Officer | 0.09% |
| Raymond Cohen | Independent Director | 0.08% |
| Mary Ladone | Independent Director | 0.06% |
| Timothy Moran | Chief Business Officer | 0.05% |
| Vaseem Mahboob | Chief Financial Officer | 0.03% |
| Jeffrey Schwartz | Independent Chairperson | 0.01% |
| Elizabeth Kwo | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-02 | Timothy Moran | Chief Business Officer | Open Market Disposition | -3,192 | $29.56 |
| 2026-10-28 | Vaseem Mahboob | Chief Financial Officer | Derivative Exercise and Sale | -79,500 | $17.00–30.60 |
| 2026-10-28 | Vaseem Mahboob | Chief Financial Officer | Intent to Sell (Form 144) | -4,788 | $30.60 |
| 2026-10-27 | Vaseem Mahboob | Chief Financial Officer | Intent to Sell (Form 144) | -39,903 | $30.48 |
| 2026-10-26 | Traci Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | Intent to Sell (Form 144) | -30,000 | $30.03 |
| 2026-10-26 | Traci Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | Derivative Exercise and Sale | -30,000 | $17.00–30.03 |
| 2026-10-26 | Vaseem Mahboob | Chief Financial Officer | Intent to Sell (Form 144) | -34,809 | $30.04 |
| 2026-10-20 | Traci Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director | Derivative Exercise and Sale | -100,000 | $17.00–28.09 |
| 2026-10-19 | Brian Webster | Chief Executive Officer | Automatic Disposition | -15,000 | $29.52–29.89 |
| 2026-09-29 | Raymond Cohen | Independent Director | Open Market Disposition | -3,330 | $29.28 |
| 2026-09-20 | Elizabeth Kwo | Independent Director | Open Market Disposition | -4,010 | $24.26 |
| 2026-09-08 | Raymond Cohen | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Mary Ladone | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Conor Hanley | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Jeffrey Schwartz | Independent Chairperson | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Elizabeth Kwo | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-08 | Kevin Reilly | Independent Director | Other Acquisition | +7,217 | -- |
| 2026-09-07 | Mary Ladone | Independent Director | Open Market Disposition | -3,908 | $25.20 |
| 2026-09-07 | Conor Hanley | Independent Director | Open Market Disposition | -5,694 | $25.25 |
| 2026-09-07 | Jeffrey Schwartz | Independent Chairperson | Open Market Disposition | -3,890 | $25.18 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Kestra Medical Technologies discussion 0 comments